Together, these factors create a poorly immunogenic tumor state, characterized by low CD8+ T-cell infiltration and a lack of tertiary lymphoid structures, leading to response rates below 30% to checkpoint inhibitors in solid tumors [69–71]. This evidence concerns the gene CD8A and neoplasm.